Active Ingredient Dabrafenib Mesylate
Active Ingredient Details
What is the usage for Dabrafenib Mesylate?
Dabrafenib may be used alone or in combination with another medication (trametinib) to treat a type of skin cancer (melanoma). It is also used with trametinib to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Dabrafenib works by slowing the growth of cancer cells.
How many products in the NDC database contain Dabrafenib Mesylate?
The NDC database has 7 products with the active ingredient Dabrafenib Mesylate. The following table lists all the products that have this active ingredient.
NDC Products with Dabrafenib Mesylate
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0681 | Proprietary Name: Tafinlar | Dabrafenib | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0078-0682 | Proprietary Name: Tafinlar | Dabrafenib | Capsule | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0078-1154 | Proprietary Name: Tafinlar | Dabrafenib | Tablet, For Suspension | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 50384-6600 | Proprietary Name: | Dabrafenib Mesylate | Powder | Sterling Pharma Solutions Limited | ACTIVE | ||
| 54893-0052 | Proprietary Name: | Dabrafenib Mesylate | Powder | Msn Laboratories Private Limited | ACTIVE | ||
| 81719-015 | Proprietary Name: | Dabrafenib Mesylate | Capsule | Siegfried Barbera, Sl | ACTIVE | ||
| 81719-016 | Proprietary Name: | Dabrafenib Mesylate | Capsule | Siegfried Barbera, Sl | ACTIVE |